Understanding MCADD: The Basics
At a Glance
Children diagnosed with MCADD through newborn screening can live completely normal, healthy lives with proper management. The primary treatment is avoiding prolonged fasting by following strict feeding schedules and giving extra carbohydrates during illnesses to prevent dangerous blood sugar drops.
Receiving an urgent call about your baby’s newborn screening can be one of the most frightening moments of parenthood. It is natural to feel overwhelmed, but there is an immediate and vital silver lining: the fact that you know this diagnosis now is a lifesaving advantage [1][2]. Because of newborn screening, your child can be protected from the risks that previously affected children who weren’t diagnosed until they became ill [1].
With proper management, children with MCADD (Medium-Chain Acyl-CoA Dehydrogenase Deficiency) typically live healthy, active, and long lives [3][4].
Three Facts to Hold On To
If you are feeling panicked, keep these three points in mind:
- The “Healthy” Diagnosis: Between illnesses, children with MCADD are usually completely healthy, grow normally, and have no physical or intellectual disabilities [4][5].
- A Simple “Medicine”: The primary treatment isn’t a complex drug or surgery—it is simply ensuring your child eats regularly and receives extra sugar (carbohydrates) when they are sick [6][7].
- Normal Future: Most children with MCADD grow into healthy adults who can participate in sports, go to college, and have families of their own [3][4].
Understanding MCADD: The Backup Battery Analogy
To understand MCADD, it helps to think of the body’s energy system like a phone battery.
- The Main Battery: Your body’s primary energy source is glucose (sugar) from the food you eat.
- The Backup Battery: When you haven’t eaten for a while (fasting) or when you are sick, your body normally switches to its “backup battery” by burning stored body fat for energy [8].
In children with MCADD, the “backup battery” doesn’t work properly [8]. Their bodies struggle to break down medium-chain fats into energy. As long as the “main battery” (regular meals) is charged, they feel fine. But if they go too long without eating, they run out of energy because they cannot access their fat stores [5][9].
What is Hypoketotic Hypoglycemia?
This is the medical term for the primary risk in MCADD. It breaks down into two parts:
- Hypoglycemia: This means low blood sugar. Since the body can’t use fat for energy, it uses up all its sugar stores very quickly during fasting [6].
- Hypoketotic: Normally, when the body burns fat, it creates “ketones” (a backup fuel for the brain). In MCADD, the body cannot make these ketones [8].
Hypoketotic hypoglycemia is dangerous because the brain is deprived of its main fuel (sugar) and has no backup fuel (ketones) to use instead [6]. This is why preventing long periods of fasting is the cornerstone of MCADD care [5].
Managing MCADD Daily
Management focuses on one main goal: avoiding prolonged fasting [9].
- Safe Fasting Intervals: Your metabolic specialist will give you a specific schedule for how often your baby must eat. This interval usually gets longer as the child grows older.
- Illness Protocols: When a child has a fever, is vomiting, or refuses to eat, they are at higher risk for a metabolic crisis. In these moments, parents follow a “stress protocol” which involves giving specific high-carbohydrate drinks [7].
- Emergency Care: If a child cannot keep down their emergency fluids, they must go to the hospital to receive intravenous (IV) glucose (sugar through a vein) to keep their energy levels stable [10][7].
Common Misunderstandings
- “They can never eat fat”: This is not true for regular fats. Children with MCADD do not typically need a fat-free diet; they just need to avoid relying on their own body fat for energy during long fasts. However, Medium-Chain Triglycerides (MCTs)—often found in coconut oil, MCT oil, and trendy health supplements—must be strictly avoided. Because your child’s enzyme specifically cannot process medium-chain fats, ingesting these directly loads the broken enzyme and causes toxic buildup [8].
- “They need special supplements”: While doctors used to prescribe carnitine (a supplement that helps process fats), current research suggests routine supplementation is often not necessary for all patients [11]. Always follow your specialist’s specific advice.
- “They will be sickly”: While you may have more frequent doctor visits or hospitalizations during the “toddler years” of daycare germs, children with MCADD are not chronically ill [12].
Common questions in this guide
What is the maximum time my baby with MCADD can safely go between feedings?
What should I do if my child with MCADD gets sick or is vomiting?
Can a child with MCADD live a normal life?
Are there specific foods children with MCADD need to avoid?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the maximum time my baby can safely go between feedings at their current age?
- 2.Can you provide us with an official 'Emergency Letter' to give to ER doctors if my child gets sick?
- 3.What is the specific recipe for the emergency high-carbohydrate drink we should use at home?
- 4.Who is the on-call metabolic specialist we should contact if our child is vomiting or won't eat?
- 5.Are there any specific medications or vaccinations we should be cautious about?
- 6.How often will we need to follow up with the metabolic clinic for monitoring?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Sudden neonatal death in individuals with medium-chain acyl-coenzyme A dehydrogenase deficiency: limit of newborn screening.
Mütze U, Nennstiel U, Odenwald B, et al.
European journal of pediatrics 2022; (181(6)):2415-2422 doi:10.1007/s00431-022-04421-y.
PMID: 35294644 - 2
Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.
Anderson DR, Viau K, Botto LD, et al.
Molecular genetics and metabolism 2020; (129(1)):13-19 doi:10.1016/j.ymgme.2019.11.006.
PMID: 31836396 - 3
Medium-chain Acyl-COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment.
Mason E, Hindmarch CCT, Dunham-Snary KJ
Endocrinology, diabetes & metabolism 2023; (6(1)):e385 doi:10.1002/edm2.385.
PMID: 36300606 - 4
Clinical, Biochemical, and Molecular Analyses of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Chinese Patients.
Gong Z, Liang L, Qiu W, et al.
Frontiers in genetics 2021; (12()):577046 doi:10.3389/fgene.2021.577046.
PMID: 33841490 - 5
Child Neurology: medium-chain acyl-coenzyme A dehydrogenase deficiency.
Gartner V, McGuire PJ, Lee PR
Neurology 2015; (85(4)):e37-40 doi:10.1212/WNL.0000000000001786.
PMID: 26215884 - 6
Coexistence of medium chain acyl-CoA dehydrogenase deficiency (MCADD) and type 1 diabetes (T1D): a management challenge.
Afreh-Mensah D, Agwu JC
BMJ case reports 2021; (14(3)) doi:10.1136/bcr-2020-239325.
PMID: 33762273 - 7
A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net.
Rossi A, Hoogeveen IJ, Lubout CMA, et al.
Journal of inherited metabolic disease 2021; (44(5)):1124-1135 doi:10.1002/jimd.12386.
PMID: 33844307 - 8
Medium-chain acyl-coenzyme A dehydrogenase deficiency: Six cases in the Chinese population.
Li Y, Zhu R, Liu Y, et al.
Pediatrics international : official journal of the Japan Pediatric Society 2019; (61(6)):551-557 doi:10.1111/ped.13872.
PMID: 31033143 - 9
Management Principles for Acute Illness in Patients With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency.
McGregor TL, Berry SA, Dipple KM, et al.
Pediatrics 2021; (147(1)) doi:10.1542/peds.2020-040303.
PMID: 33372121 - 10
A retrospective review of anesthesia and perioperative care in children with medium-chain acyl-CoA dehydrogenase deficiency.
Allen C, Perkins R, Schwahn B
Paediatric anaesthesia 2017; (27(1)):60-65 doi:10.1111/pan.13065.
PMID: 27896927 - 11
Plasma carnitine concentrations in Medium-chain acyl-CoA dehydrogenase deficiency: lessons from an observational cohort study.
Jager EA, Schaafsma M, van der Klauw MM, et al.
Journal of inherited metabolic disease 2022; (45(6)):1118-1129 doi:10.1002/jimd.12537.
PMID: 35778950 - 12
Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada.
Karaceper MD, Khangura SD, Wilson K, et al.
Orphanet journal of rare diseases 2019; (14(1)):70 doi:10.1186/s13023-019-1001-0.
PMID: 30902101
This page provides general educational information about MCADD. Always follow your metabolic specialist's specific feeding schedules and emergency illness protocols for your child.
Get notified when new evidence is published on Medium chain acyl-CoA dehydrogenase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.